AU2001277997A1 - Diagnostic polymorphisms for the tgf-beta1 promoter - Google Patents

Diagnostic polymorphisms for the tgf-beta1 promoter

Info

Publication number
AU2001277997A1
AU2001277997A1 AU2001277997A AU7799701A AU2001277997A1 AU 2001277997 A1 AU2001277997 A1 AU 2001277997A1 AU 2001277997 A AU2001277997 A AU 2001277997A AU 7799701 A AU7799701 A AU 7799701A AU 2001277997 A1 AU2001277997 A1 AU 2001277997A1
Authority
AU
Australia
Prior art keywords
beta1
tgf
promoter
diagnostic polymorphisms
polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277997A
Inventor
David W. Moskowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DZGENES LLC
Original Assignee
DZGENES LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DZGENES LLC filed Critical DZGENES LLC
Publication of AU2001277997A1 publication Critical patent/AU2001277997A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001277997A 2000-07-25 2001-07-25 Diagnostic polymorphisms for the tgf-beta1 promoter Abandoned AU2001277997A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22058300P 2000-07-25 2000-07-25
US60220583 2000-07-25
PCT/US2001/023368 WO2002008468A1 (en) 2000-07-25 2001-07-25 Diagnostic polymorphisms for the tgf-beta1 promoter

Publications (1)

Publication Number Publication Date
AU2001277997A1 true AU2001277997A1 (en) 2002-02-05

Family

ID=22824111

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277997A Abandoned AU2001277997A1 (en) 2000-07-25 2001-07-25 Diagnostic polymorphisms for the tgf-beta1 promoter

Country Status (5)

Country Link
US (1) US20040209254A1 (en)
EP (1) EP1307590A4 (en)
AU (1) AU2001277997A1 (en)
CA (1) CA2417460A1 (en)
WO (1) WO2002008468A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002323841B2 (en) * 2001-06-05 2008-05-22 Auckland Uniservices Limited Methods and compositions for assessment of pulmonary function and disorders
JP4682312B2 (en) * 2003-09-04 2011-05-11 学校法人日本大学 TGF-β gene expression inhibitor
US7858763B2 (en) 2004-06-04 2010-12-28 Council Of Scientific And Industrial Research Transforming growth factor beta 1 (TGFβ1) haplotypes and prediction of susceptibility for immunological disorders
KR100851971B1 (en) 2005-05-21 2008-08-12 삼성전자주식회사 Genetic polymorphisms associated with myocardial infarction and uses thereof
KR100760297B1 (en) 2005-07-06 2007-09-19 대한민국(관리부서 질병관리본부장) - Genetic Polymorphisms in the Transforming Growth Factor Beta-Induced Gene Associated with Body Mass Index
WO2009055480A2 (en) * 2007-10-22 2009-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tgf-beta gene expression signature in cancer prognosis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1323553C (en) * 1987-11-03 1993-10-26 Timothy George Helentjaris Method and device for improved restriction fragment length polymorphism analysis
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
US6013431A (en) * 1990-02-16 2000-01-11 Molecular Tool, Inc. Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
US5494810A (en) * 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5846710A (en) * 1990-11-02 1998-12-08 St. Louis University Method for the detection of genetic diseases and gene sequence variations by single nucleotide primer extension
US5888819A (en) * 1991-03-05 1999-03-30 Molecular Tool, Inc. Method for determining nucleotide identity through primer extension
ATE198358T1 (en) * 1992-04-27 2001-01-15 Dartmouth College DETECTION OF GENE SEQUENCES IN BIOLOGICAL LIQUIDS
US5925517A (en) * 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5834181A (en) * 1994-07-28 1998-11-10 Genzyme Corporation High throughput screening method for sequences or genetic alterations in nucleic acids
US5866323A (en) * 1995-04-07 1999-02-02 Case Western Reserve University Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors
JP3439221B2 (en) * 1995-12-18 2003-08-25 ワシントン ユニヴァーシティ Nucleic acid analysis method using fluorescence resonance energy transfer
AU723751B2 (en) * 1996-01-17 2000-09-07 Sequenom-Gemini Limited Diagnostic method and apparatus
US5645995A (en) * 1996-04-12 1997-07-08 Baylor College Of Medicine Methods for diagnosing an increased risk for breast or ovarian cancer
EP0955378A1 (en) * 1998-04-06 1999-11-10 Bente Lomholt Langdahl Method and kit for detecting a sequence variation in the human TGF-beta 1 gene

Also Published As

Publication number Publication date
EP1307590A4 (en) 2005-01-12
EP1307590A1 (en) 2003-05-07
CA2417460A1 (en) 2002-01-31
US20040209254A1 (en) 2004-10-21
WO2002008468A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU5546000A (en) Compounds
AU1278701A (en) Novel compounds
AU2001271434A1 (en) Novel skateboard-bicycle combination
AUPQ253199A0 (en) Non-prostanoid prostaglandin I2-agonist
AU2001259561A1 (en) Tgfbeta-rii promoter polymorphisms
AU2408300A (en) Novel compounds
AU1746401A (en) Compounds
GB9914210D0 (en) Promoter
AU3997700A (en) Anti-first-pass effect compounds
AU2001277997A1 (en) Diagnostic polymorphisms for the tgf-beta1 promoter
AU2001277581A1 (en) Myocardium-specific promoter
AU1897401A (en) Multiple drawer-type charnel unit
AU4132200A (en) Novel compounds
AU2109700A (en) Novel compounds
AU2001249446A1 (en) Diagnostic polymorphisms of tgf-beta-rii promoter
AU6550800A (en) Hepoxilin analogs
AU2001280752A1 (en) Diagnostic polymorphisms for the ecnos promoter
EP1077257A4 (en) Photoinhibitory promoter
AU5119400A (en) Compounds
AU2288900A (en) Novel compounds
AU2001287278A1 (en) Diagnostic polymorphisms of tgf-beta 1 promoter
AU2668000A (en) Bis-styrylbiphenyl compounds
AU6168900A (en) Compounds
AU4156800A (en) Novel compounds
AU1385701A (en) Novel compounds